Federal
Emergency Support for Substance Use Disorders Act
Source: Congress.gov ·
1,077 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
117TH CONGRESS
1ST SESSION
S. 166
To authorize grants to address substance use during COVID–19.
IN THE SENATE OF THE UNITED STATES
FEBRUARY 2, 2021
Ms. SMITH (for herself and Ms. MURKOWSKI) introduced the following bill;
which was read twice and referred to the Committee on Health, Edu-
cation, Labor, and Pensions
A BILL
To authorize grants to address substance use during
COVID–19.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Emergency Support
4
for Substance Use Disorders Act’’.
5
SEC. 2. FINDINGS.
6
Congress finds the following:
7
(1) In 2018, an estimated 164,800,000 people
8
aged 12 or older in the United States, or 60.2 per-
9
cent of such population, were substance users (in-
10
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
2
•S 166 IS
cluding, tobacco, alcohol, or illicit drugs) in the last
1
month.
2
(2) In 2018, nearly 1 in 5 people aged 12 or
3
older in the United States, or 19.4 percent of such
4
population, used an illicit drug in the past year,
5
which is a higher percentage than in 2015 and
6
2016.
7
(3) In 2018, an estimated 10,300,000 people
8
aged 12 or older in the United States misused
9
opioids in the past year, including 9,900,000 pre-
10
scription pain reliever misusers and 808,000 heroin
11
users.
12
(4) In 2017, overdose deaths involving opioids
13
in the United States, including fentanyl, was 6 times
14
higher than in 1999.
15
(5) The age-adjusted rate of drug overdose
16
deaths involving synthetic opioids in the United
17
States other than methadone increased by 10 per-
18
cent from 2017 to 2018.
19
(6) In 2018, approximately 20,300,000 people
20
aged 12 or older in the United States had a sub-
21
stance use disorder related to their use of alcohol or
22
illicit drugs in the past year.
23
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
3
•S 166 IS
(7) In 2018, an estimated 21,200,000 people
1
aged 12 or older in the United States needed sub-
2
stance use treatment.
3
(8) According to the Substance Abuse and Men-
4
tal Health Services Administration, COVID–19 will
5
certainly contribute to growth in the numbers re-
6
ferred to in the preceding paragraphs. Individuals
7
across the United States will struggle with increases
8
in depression, anxiety, trauma, and grief. There is
9
also anticipated increase in substance misuse in the
10
United States as lives are impacted for individuals
11
and families.
12
SEC. 3. GRANT PROGRAM ON HARMS OF DRUG MISUSE.
13
(a) IN GENERAL.—The Assistant Secretary for Men-
14
tal Health and Substance Use (referred to in this section
15
as the ‘‘Assistant Secretary’’), in consultation with the Di-
16
rector of the Centers for Disease Control and Prevention,
17
shall award grants to States, political subdivisions of
18
States, Tribes, Tribal organizations, and community-based
19
entities to support the delivery of overdose prevention, sy-
20
ringe services programs, and other harm reduction serv-
21
ices that address the harms of drug misuse during the
22
COVID–19 pandemic, including by—
23
(1) preventing and controlling the spread of in-
24
fectious diseases, such as HIV/AIDS and viral hepa-
25
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
4
•S 166 IS
titis, and the consequences of such diseases for indi-
1
viduals with substance use disorder;
2
(2) distributing opioid antagonists, such as
3
naloxone, to individuals at risk of overdose;
4
(3) connecting individuals at risk for, or with,
5
a substance use disorder to overdose education,
6
counseling, and health education; and
7
(4) encouraging such individuals to take steps
8
to reduce the negative personal and public health
9
impacts of substance use or misuse during the emer-
10
gency period.
11
(b) CONSIDERATIONS.—In awarding grants under
12
this section, the Assistant Secretary shall prioritize grants
13
to applicants that are—
14
(1) culturally specific organizations, Tribal be-
15
havioral health and substance use disorder providers,
16
or organizations that are intentional about serving
17
populations where COVID–19 has had the most im-
18
pact; or
19
(2) proposing to serve areas with—
20
(A) a higher proportion of the population
21
who meet criteria for dependence on, or abuse
22
of, illicit drugs;
23
(B) a higher drug overdose death rate;
24
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
5
•S 166 IS
(C) a greater telemedicine infrastructure
1
need; and
2
(D) a greater behavioral health and sub-
3
stance use disorder workforce need.
4
(c) USE OF GRANT AWARDS.—A recipient of a grant
5
under this section may use such grant funds for the fol-
6
lowing purposes:
7
(1) Adapt, maintain, and expand essential serv-
8
ices provided by harm reduction service organiza-
9
tions to address the risks of COVID–19, drug over-
10
dose, and contraction of infectious disease.
11
(2) Maintain or hire staff.
12
(3) Support program operational costs, includ-
13
ing staff, rent, and vehicle purchase or maintenance.
14
(4) Program supplies.
15
(5) Hygiene and personal protective equipment
16
for both staff and program participants.
17
(6) Support and case management services.
18
(d) DEFINITION.—In this section, the term ‘‘emer-
19
gency period’’ has the meaning given to such term in sec-
20
tion 1135(g)(1)(B) of the Social Security Act (42 U.S.C.
21
1320b–5(g)(1)(B)).
22
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry
23
out this section, there is authorized to be appropriated
24
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
6
•S 166 IS
$50,000,000 for fiscal year 2021, to remain available until
1
expended.
2
Æ
VerDate Sep 11 2014
20:48 Feb 14, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\S166.IS
S166
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.